Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Nidan Laboratories And Healthcare Ltd (NIDAN)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: NIDAN Hospital & Healthcare Services | Small Cap | Nidan Labs. & Health Share Price
BSE Share Price
Not Listed
Not Listed
Nidan Laboratories And Healthcare Ltd (NIDAN)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: NIDAN Hospital & Healthcare Services | Small Cap | Nidan Labs. & Health Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹17 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
98.6
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
1.45%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
57.04%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹13.9 Cr.
Face Value
₹10
All Time Low / High
₹0.00 / 0.00
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Nidan Laboratories And Healthcare Ltd a good quality company?
Nidan Laboratories And Healthcare Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Nidan Laboratories And Healthcare Ltd performance compare with that of its Peers?
Revenue growth of Nidan Laboratories And Healthcare Ltd vs industry peers?
Nidan Laboratories And Healthcare Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Nidan Laboratories And Healthcare Ltd?
Promoters hold 57.04% of the Nidan Laboratories And Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Nidan Laboratories And Healthcare Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -25.41% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Nidan Laboratories And Healthcare Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 11.7% | 10.2% | 14% | 10.5% | 8.5% | -0.2% | 6.2% | - |
| Value Creation Index ⓘ | -0.2 | -0.3 | -0 | -0.3 | -0.4 | -1.0 | -0.6 | - |
Growth Parameters ⓘ |
||||||||
| Sales ⓘ | 20.1 | 21.4 | 20.4 | 29.7 | 24.3 | 24.2 | 24.5 | 26 |
| Sales YoY Gr. | - | 6.7% | -4.8% | 45.5% | -18.2% | -0.4% | 1.5% | - |
| Adj EPS ⓘ | 0.2 | 0.7 | 2.3 | 1.8 | 2.4 | 1 | 1.4 | 1.1 |
| YoY Gr. | - | 213% | 223.6% | -24% | 36.2% | -60.6% | 48.4% | - |
| BVPS (₹) ⓘ | 10.4 | 11.1 | 13.5 | 47.4 | 50 | 47.6 | 49.1 | 49.1 |
| Adj Net Profit ⓘ | 0.2 | 0.7 | 2.3 | 2.5 | 3.4 | 1.3 | 2 | 2 |
| Cash Flow from Ops. ⓘ | 9 | 4.6 | 4.4 | 7.8 | 11 | 5.5 | 2.3 | - |
| Debt/CF from Ops. ⓘ | 3.6 | 7.4 | 8.8 | 2.5 | 1 | 2.3 | 4.9 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 2.8% | -6.1% | 1.5% | ||||
| Adj EPS ⓘ | NA | 14.4% | -7.3% | 48.4% | ||||
| BVPSⓘ | NA | 34.5% | 1.1% | 3% | ||||
| Share Price | - | - | -26.1% | -33.2% | ||||
Key Financial Parameters ⓘ
| Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 2.2 | 6.7 | 18.9 | 6.2 | 5 | 2 | 2.9 | 2.2 |
| Op. Profit Mgn % ⓘ | 39.1 | 35.7 | 43.6 | 31.7 | 28 | 26.7 | 20.6 | NAN |
| Net Profit Mgn % ⓘ | 1.1 | 3.3 | 11.3 | 8.3 | 13.8 | 5.5 | 8 | 5.9 |
| Debt to Equity ⓘ | 3.1 | 3.1 | 2.9 | 0.3 | 0.2 | 0.2 | 0.2 | - |
| Working Cap Days ⓘ | 0 | 269 | 383 | 501 | 825 | 868 | 779 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 89 | 78 | 39 | 73 | 43 | 0 | 0 |
Valuation of Nidan Labs. & Health - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Nidan Laboratories And Healthcare Ltd FAQs
The current trading price of Nidan Labs. & Health on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Nidan Labs. & Health stood at ₹17.44 Cr
The latest P/E ratio of Nidan Labs. & Health as of 31-Dec-1969 is 11.58.
The latest P/B ratio of Nidan Labs. & Health as of 31-Dec-1969 is 0.26.
The 52-week high of Nidan Labs. & Health is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nidan Labs. & Health is ₹25.54 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Nidan Laboratories And Healthcare Ltd is a below average quality company.
The key valuation ratios of Nidan Laboratories And Healthcare Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Nidan Laboratories And Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Nidan Laboratories And Healthcare Ltd
Nidan Laboratories and Healthcare was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 5, 2000 under the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, Maharashtra. Subsequently, the name of the company was changed from “Abhi Diagnostic Imagings Private Limited” to “Nidan Laboratoris And Healthcare Private Limited” under the Companies Act, 2013 pursuant to a special resolution passed by its shareholders at the EGM held on February 26, 2021 and had obtained fresh certificate of incorporation dated March 24, 2021 issued by the Registrar of Companies, Maharashtra. Subsequently, the company was converted into a public limited company and the name of the company was changed to ‘Nidan Laboratories And Healthcare Limited’ and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Mumbai, Maharashtra, on May 24, 2021.
The company was established as a proprietary Firm in 1994 by its Promoter- Dr. Nitin Vithalrao Throve in the Northern District of Mumbai where diagnostic services was provided under one roof at reliable and affordable price. The business was carried out under sole proprietorship, which was later taken over by the company in 2000. From the year 2000, he expanded the diagnostic’s business by setting up various centre’s within the Northern District of Mumbai and Pune and Southern District of Pune.
Business area of the company
The company offers diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
